Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients, and Company Appoints CEO and President

Posted on June 10, 2024

SAN MATEO, Calif., June 10, 2024 /PRNewswire/ — Cala, the bioelectronic medicine leader, reached a major milestone: a positive Medicare Local Coverage Determination for the Cala TAPS (Transcutaneous Afferent Patterned Stimulation) Therapy for essential tremor (ET) from the Centers for Medicare & Medicaid Services (CMS):  External Upper Limb Tremor Stimulator Therapy L39591. Medicare beneficiaries who qualify under the new coverage guidelines now have access to Cala TAPS therapy to treat their hand tremor.

Leave a Reply

Your email address will not be published. Required fields are marked *